InspireMD, Inc. Cash Flow Statement
NSPR|14 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 14 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
-$22M
FY2025
Free Cash Flow
-$23M
FY2025
Capital Expenditures
$1M
Cash used for long-term assets
Dividends Paid
N/A
FY2025
InspireMD, Inc. used $22M in operating cash flow and negative free cash flow of $23M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$32.0M | -$19.9M | -$18.5M | -$14.9M | -$10.5M | -$10.0M | -$7.2M | -$8.4M | -$8.5M | -$15.6M | -$25.1M | -$17.6M | -$17.6M | -$2.7M |
| Depreciation & Amortization | $280.0M | $232.0M | $188.0M | $161.0K | $151.0K | $158.0K | $139.0K | $153.0K | $142.0K | $152.0K | $163.0K | $120.0K | $120.0K | $89.0K |
| Operating Cash Flow | -$21.9M | -$16.4M | -$15.5M | -$13.2M | -$9.1M | -$9.8M | -$7.6M | -$8.1M | -$7.5M | -$11.6M | -$19.4M | -$8.6M | -$8.6M | -$1.5M |
| Capital Expenditures | $1.4M | $381.0K | $473.0K | $344.0K | $88.0K | $284.0K | $67.0K | $258.0K | $49.0K | $16.0K | $133.0K | $290.0K | $290.0K | $34.0K |
| Free Cash Flow | -$23.3M | -$16.8M | -$16.0M | -$13.6M | -$9.2M | -$10.1M | -$7.7M | -$8.4M | -$7.5M | -$11.6M | -$19.5M | -$8.9M | -$8.9M | -$1.6M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | $21.0K | $21.0K | - |
| FCF Margin | -332.0% | -270.1% | -309.7% | -301.5% | -369.0% | -271.3% | -213.1% | -303.8% | -398.3% | -502.7% | -691.8% | -165.8% | -165.8% | -46.3% |